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Background. Although engagement of infectious disease physicians has been demonstrated to improve clinical outcomes in a
variety of disease states, the extent of infectious disease (ID) physician engagement in quality improvement (QI) or their knowledge
of QI has not been assessed.
Methods. A 12-question, web-based survey was distributed to members of the Infectious Diseases Society of America (IDSA)
between August and October 2019 to assess knowledge of and engagement in QI. The survey link was sent to IDSA members who
self-identified patient care as their primary professional activity.
Results. Responses were received from 200 individuals (5.4% response rate, which is just below the standard IDSA survey
response rate of 6%), consisting of 175 adult infectious disease physicians (IDPs). Most respondents were employed in a hospital
or clinic (41%), private or group practice (25%), or university/medical center (24%). Fifty-eight percent of respondents currently
participate in QI projects, while 38% serve on QI oversight committees. Among respondents, 27% reported not being engaged in
QI. Infection prevention/hospital epidemiology (77%), stewardship (72%), and antimicrobial resistance (56%) were the most commonly reported measure types. Respondents reported barriers that limited participation in QI, including cost (61%), lack of time
(56%), lack of data collection resources (48%), and lack of an ID-specific registry (46%). IDPs report significant interest in additional
training in QI and new quality measures.
Conclusions. Although IDPs participate in QI, there are gaps in QI knowledge and measurement systems. The low response rate
of our survey also suggests a lack of engagement in QI among IDPs. Closing these gaps will benefit ID in a value-driven health care
economy.
Keywords. clinical practice; measurement; quality; value.
Infectious diseases (ID) specialists in the United States have
expressed concern about the future of the specialty [1, 2] due
to a decline in the number of ID fellowship trainees [3] and
low reimbursement compared with other specialties [4, 5].
One of the ways to improve the appeal of ID to trainees and
to promote compensation comparable to the impact and work
of infectious disease physicians (IDPs) is to demonstrate the
value of IDPs, a top priority of the Infectious Diseases Society
of America (IDSA) [6]. Demonstrating value requires measurement of the impact of IDPs on patient care and institutional
success. Thus, promoting a culture of quality improvement and
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measurement within the specialty of ID is critical to the future
of the specialty.
Literature has demonstrated that involvement of IDPs in
patient care for a multitude of diseases improves patient outcomes, improves quality of patient care, reduces cost of care,
and benefits population health [7–10]; in order to translate this
evidence into measurement of quality and performance for the
care of patients, both well-defined measures and engagement
of IDPs in quality and performance measurement are needed.
Other medicine specialties have made this successful transition
from evidence that an intervention is beneficial to quality and
performance improvement in the workplace, and subsequently
to demonstration of value within an institution. For example,
literature-based quality measures were developed for cardiology,
implemented through quality improvement, and ultimately reflected in national institutional reputation [11–13]. With the
shift to value-based reimbursement, properly designed measures also provide the benefit of use for pay-for-performance
reimbursement [14], another way to demonstrate IDP value.
In sum, developing a culture of measurement in infectious diseases requires both measures of IDP-impacted quality and engagement of IDPs in quality improvement and measurement.
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METHODS

The target population for the survey was physician IDSA members based in the United States whose primary professional
activity was patient care, primary employment affiliation was
at a university/medical school, hospital/clinic, private/group
practice, federal government, state/local government, military,
correctional facility, or other, and specialization was in adult infectious diseases. The target population was contacted by direct email with a personalized SurveyMonkey Inc. (San Mateo,
CA, USA) link that contained a custom identifier that enabled
linkage to the IDSA membership database to include demographic data in our analysis. The target population amounted
to 3685 contacts out of ~12 000 total IDSA members (October
2019). Additional survey responses were solicited through the
IDSA’s Volunteer Manager web portal, which lists all IDSA volunteer opportunities. The survey collection period was from
August 2019 to October 2019, with a total of 200 respondents
(5.4% response rate). As a comparator, the average response
rate for IDSA member surveys is ~6%. The survey has been reviewed by the authors’ affiliated institutional review boards and
was designated as an exempt study.
The survey asked respondents a total of 12 questions. The complete list of questions and answer options is available in Table 1.
RESULTS

We surveyed members of the IDSA through their member registry system. A total of 200 respondents completed the survey,
with 199 completing all 12 questions. Of the respondents, 175
practice adult ID, 13 practice pediatric ID, and 2 practice internal medicine. Specialty field data were not available from 9
respondents. Most of the respondents were employed in a hospital or clinic (41%), private or group practice (25%), or in a
university/medical center (24%). Ninety-four percent of the respondents reported patient care as their primary job role, with
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inpatient practice being the most common (78%). Teaching
(34%) followed by clinical research (19%) and hospital epidemiology (17%) were the most common secondary job roles. Fiftyeight percent of the respondents reported that they participate
in quality improvement projects, with 38% serving on a quality
improvement oversight committee. Twenty-seven percent of
the respondents are not actively involved in quality improvement (Figure 1).
Most respondents reported that their facility collects data to
be used for hospital-based quality improvement efforts (54%)
and Centers for Medicare and Medicaid Services (CMS), Heath
Resources and Services Administration, or private payer quality
programs (46%). Data may also be used to promote improvement in the quality of patient care delivered either via ongoing professional performance evaluation (OPPE; 29%) or via
self-directed improvement (16%). Thirty-three percent of the
respondents reported that the data are also used for hospitalbased incentive programs. However, 23% of the respondents
did not know how the data collected by their hospital/practice
are used (Figure 2).
Infection prevention/hospital epidemiology (77%), stewardship (72%), and antimicrobial resistance (56%) are the
most commonly reported measure types. Antimicrobial utilization (73%) was the most commonly collected data point.
Mortality rates and readmission rates for patients who are provided care are also commonly reported, though these are not
specific to patients with infectious disease conditions such as
Staphylococcus bacteremia. Guideline & treatment standard
adherence are commonly measured as well. Those working in
a federal or state/local government position were more likely
to report also being measured on adherence to treatment
standards for non-ID-related disease states, such as tobacco
cessation.
Several barriers to participation in quality improvement
were identified. A deficiency in knowledge on how to collect
quality data was not a major barrier for any subgroup. The lack
of support for data collection, access to the data, and lack of
time to complete QI work were major barriers for all (Figure
3). Specifically, the lack of ID-specific measures and the lack of
an ID data registry were barriers, with the majority of respondents reporting that they would be very likely to use ID-specific
quality metrics if more existed (Figure 4). Many respondents
also reported that they would utilize QI resources through the
IDSA, such as webinar trainings (77%), IDWeek lectures (73%),
a data registry (51%), or fellowship-directed educational tools
(29%).
CONCLUSIONS

Health care payment models in the United States have historically been based on payment for volume. However, the growing
trend toward value-based care provides incentive for health care
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The current level of interest or involvement in quality improvement among IDPs has not been adequately assessed. A review of
the literature indicates that IDPs are involved in local and collaborative quality improvement efforts [7–10]. In addition, many of the
institutional positions of IDPs such as hospital epidemiology, antimicrobial stewardship, and outpatient parenteral antibiotic therapy
require some degree of understanding of quality improvement.
Due to the paucity of existing national ID-specific measures and
lack of benchmarked goals for the few existing measures, IDPs do
not appear superficially to be heavily involved in quality improvement nationally [14, 15]. To more thoroughly assess the current
involvement of IDPs in QI and measurement, we surveyed IDP
members of the Infectious Diseases Society of America. Herein,
we review the survey results and propose strategies for addressing
gaps so that IDPs can move toward a culture of measurement and
quality improvement that will promote the success of the specialty.

Table 1. Survey Questions and Answers
Question

Answer Options

1. How are you currently involved in quality
measurement or improvement work at your
hospital/practice? (select all that apply)

A. Not actively involved; I am not sure if my practice/facility collects quality data on my care
B. Not actively involved, but I know that my practice/facility collects data on my care
C. My practice/hospital uses an outside vendor to collect data
E. I participate in quality improvement projects
F.

2. Select all the barriers to your participation
in quality improvement. If you participate in
quality improvement, select the barriers that
prevent you from greater or more successful
participation.

I serve on a quality improvement oversight or review committee

A. Mortality for all patients you provide care to
B. Mortality for patients with specific infectious disease conditions (eg, Staphylococcus
bacteremia)
C. Readmission rates for all patients you provide care to
D. Readmission rates for patients with specific infectious disease conditions
E. Adherence to guidelines from professional societies
F.

Utilization of hospital-specific treatment pathways/order sets

G. Antimicrobial utilization
H. Health maintenance (eg, smoking cessation counseling)
I.

Adherence to treatment standards for non-ID-related conditions (eg, beta-blocker use after MI,
smoking cessation)

J. Other
3. Select all quality data that you or your primary practice/hospital collect to measure the
safety or quality of care that you deliver.

A. Ongoing professional practice evaluation
B. CMS, HRSA, or private payer quality programs
C. Hospital-based incentive programs
D. Hospital-based quality improvement effort
E. Self-directed care improvement
F.

I don’t know

G. Other
4. If you or your hospital/practice collects quality
data, what are the data used for? (Select all
that apply.)

A. Lack of validated metrics that reflect ID care
B. Lack of access to data
C. Lack of support for data collection and/or reporting
D. Unclear benefit to participating in QI
E. Lack of time to complete QI work
F.

Lack of knowledge on how to improve quality

G. Cost of resources for reporting
H. Lack of ID-specific data registry
I.
5. How likely are you to use the following safety
and quality metrics if they existed? (1—very
unlikely, 5—very likely)

Infectious disease quality measurement is not an institutional priority

A. Antimicrobial use/stewardship
B. OPAT use and safety
C. Clostridium difficile guideline adherence
D. Staphylococcus aureus bacteremia guideline adherence
E. Adherence to other IDSA-endorsed guideline
F.

Adherence to HIV care standards (eg, antiretroviral use, OI prophylaxis)

G. Development of antimicrobial resistance
H. Other (specify)
6. Would you utilize any of the following resources to improve your knowledge of quality
improvement if provided by IDSA? (Select all
that apply.)

A. Webinars/trainings

7. Select all measures that you/your practice
reports on either externally or internally.

A. Stewardship

B. Fellowship educational tools
C. Data registry
D. IDWeek lectures/workshop
B. OPAT
C. HIV
D. Infection prevention/hospital epidemiology
E. Antimicrobial resistance
F.

8. Rate your familiarity with these quality
programs or methods. (1—not at all familiar,
5—extremely familiar)

Staphylococcus aureus bacteremia

A. Merit-based Incentive Payment Program (MIPS)
B. Alternative Payment Models (APMs)
C. Model for Improvement
D. Lean Methodology
E. Six Sigma
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D. I receive reports about the quality of care that I deliver

Table 1.

Contined

Question

Answer Options

9. Please describe the location where you deliver the majority of your ID care.

A. Inpatient

10. How many years have you been in practice?

A. Medical student

B. Outpatient
C. Other (specify)

C. <5 years out of fellowship
D. 5–10 years out of fellowship
E. 10–15 years out of fellowship
F.

15–20 years out of fellowship

G. 20–25 years out of fellowship
H. ≥25 years out of fellowship
11. What is the size of the facility where you
spend the majority of your time?

A. <50 beds
B. 50–100 beds
C. 100–200 beds
D. 200–400 beds
E. 400–600 beds
F.

600–800 beds

G. 800–1000 beds
H. >1000 beds
12. Would you be willing to participate in a
follow-up survey about quality & safety reporting metrics?

A. Yes
B. No

Abbreviations: CMS, Centers for Medicare and Medicaid Services; HRSA, Heath Resources and Services Administration; ID, infectious disease; IDSA, Infectious Diseases Society of
America; MI, myocardial infarction; OI, opportunistic infection; OPAT, outpatient parenteral antibiotic therapy.
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I serve on a
quality
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oversight or
review
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Medical student,
resident/fellow; n = 3

>25 years; n = 57
Figure 1.

I participate in
quality
improvement
projects
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B. Resident/Fellow
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Figure 2. Reported use of quality data, by employment type. Abbreviations: CMS, Centers for Medicare and Medicaid Services; HRSA, Heath Resources and Services
Administration.
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Figure 4. Likeliness to use potential ID quality and safety metrics (Likert scale). Abbreviations: ID, infectious disease; IDSA, Infectious Diseases Society of America; OI,
opportunistic infection; OPAT, outpatient parenteral antibiotic therapy.

providers to engage in quality measurement and improvement
activities that allow for the demonstration of value as well as improvements in care. In order to demonstrate value, there must
be systems of measurement that accurately reflect care delivery
and participation of clinicians to engage in data-driven care improvement. This survey assesses infectious disease physicians’
knowledge of and engagement with quality measurement and
improvement.
Our survey indicates that many IDPs (58%) already participate in quality improvement projects; an additional 38%
of respondents serve on quality improvement oversight or review committees. However, there is variation in engagement
in quality improvement projects based on employer, with only
33% (n = 17) of those in private or group practices reporting
participation in quality improvement projects. This is in contrast to those employed directly by a hospital (66% of respondents) or university/medical school (69% of respondents). This
difference in engagement with QI projects may be a reflection
of how participation in these activities is compensated in different settings. Compensation models that are fully supported
by the volume of patients seen will disincentivize participation
in uncompensated activities, like participation in QI initiatives.
Conversely, direct employment by a university or hospital may
weaken the link between patient volume and compensation,
thus reducing the disincentive to participate in activities that do
not directly generate revenue.
Participation in QI projects is not surprising given the
demonstrated benefits that the engagement of an IDP has on
6 • OFID • Sheridan et al

infection prevention and antimicrobial stewardship programs
[16]. Respondents indicated that infection prevention (77%),
antimicrobial stewardship (72%), and antimicrobial resistance
(56%) were the most frequently reported infectious disease–related measures collected by their facilities. By comparison, a
minority of respondents indicated that their facility reported
data on adherence to treatment guidelines (21%), hospitalbased treatment pathways or order sets (33%), or health maintenance measures (33%). Although the CMS reports 30-day
readmissions and 30-day mortality for selected conditions, including pneumonia, few IDPs were aware that data were collected on these measures. Only 23% of respondents indicated
that mortality data on all patients to whom they provided care
were collected, while only 11% reported knowledge that mortality for specific infectious disease conditions were collected.
Thirty-four percent of respondents were aware that data on readmission rates were collected for patients to whom they had
provided care.
IDPs reported that the most common use for quality data
was hospital-based improvement (54%), while only 46% reported that the data were used for CMS or other payer quality
programs. Twenty-three percent of respondents were unsure
how quality data were used. IDPs reported modest knowledge
of the 2 components of CMS’ Quality Payment program, the
Merit-Based Incentive Payment System (MIPS) and Alternate
Payment Models (APMs). Among respondents, 50.6% and
71.3% were slightly or not at all familiar with MIPS and APMs,
respectively.
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Weighted average

4.50

organizations must devote resources to. More than one-third of
respondents to our survey indicated that ID quality measures
were not an organizational priority (Figure 3). In addition to
providing insight into an ID physicians’ care, new quality measures must provide value to the health care organizations, which
are often balancing the demands of multiple quality measurement systems with the limited resources available for data collection, reporting, and improvement.
Our study does have limitations. We had a low response rate,
at only 5.4%, which may be reflective of a low level of engagement in QI among IDPs. Although survey respondents represented a broad array of ID practice types and care settings,
it is possible that participants are not representative of all ID
providers. Additionally, the survey largely assesses knowledge
of inpatient quality measures. There are several HIV-related
quality measures that assess the quality of ambulatory HIV care.
Additionally, the survey was targeted toward individuals who
reported patient care as their primary professional activity. ID
physicians who serve in safety- or quality-related administrative roles as their primary activity may have been excluded from
this study. The results reflect the knowledge and engagement in
QI of a more broadly generalizable IDP population when compared with those who are predominantly in safety or quality administrative roles.
Our study suggests that while there is interest in more
ID-related quality measures, there currently are knowledge
and other barriers that limit the ability of IDPs to participate
in quality initiatives. Initiatives to make quality improvement
training more available may benefit IDPs. Access to an ID registry may also be beneficial to advancing the role of IDPs in
QI.
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